Adcock ingram | Sustainability Performance
Manufactures and markets pharmaceuticals and healthcare products for various treatment categories. Operates production facilities with quality control and regulatory oversight. Supports healthcare providers and institutions through product availability and information services.
1890
South Africa
1,001 - 5,000 employees
Pharmaceuticals
$25M - 100M in revenue
$25M - 100M in profitability
Sustainability Ranking & Industry Benchmark
#9105
Overall#47
in South Africa#211
in PharmaceuticalsSustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Revenue
Controversy level
Powered by illuminem
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$9.8BFY2025 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
Return on invested capital
14.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
9.1
▼ 0.3%
9.6
▼ 0.6%
9.8
▼ 1.1%
11.2
2028Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Available
Human rights policy
Available
Recycling policy
Available
Workplace health & safety policy
Available
24%
Independent Directors
5 out of 21 incl. management
Overall score
62
Environment
60
Social
99
Governance
27
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
